STAT

NOVEMBER 7, 2024

In the last year, drugmakers have talked up the prospect of medicines discovered or designed by artificial intelligence.

349

349

Pharma Times

NOVEMBER 7, 2024

Trial to evaluate safety and efficacy of MVA-BN vaccine

Vaccines 130

Vaccines 130

PharmaVoice

NOVEMBER 7, 2024

Pioneers like Alnylam Pharmaceuticals have led the RNA interference field for years. Now, a crop of young biotechs is building on that foundation by taking the drugmaking technology in new directions.

130

130

Pharma Times

NOVEMBER 7, 2024

New initiatives to tackle AI-related challenges in life sciences

124

124

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Communication

pharmaphorum

NOVEMBER 7, 2024

Sarepta has halted development of vesleteplirsen, a follow-up to its Duchenne muscular dystrophy therapy Exondys 51.

115

115

BioPharma Dive

NOVEMBER 7, 2024

Elevidys sales have increased since the FDA made a controversial choice to expand the therapy's use. Now, Sarepta is abandoning a successor to its drug Exondys 51, citing an “evolving" treatment landscape.

115

115

Express Pharma

NOVEMBER 7, 2024

On 7 November 2024, the U.S. Food and Drug Administration (FDA) announced a proposal to remove oral phenylephrine from over-the-counter (OTC) drugs marketed as nasal decongestants. The proposal follows an agency review that concluded oral phenylephrine is ineffective in providing temporary relief of nasal congestion. Until a final order is issued, however, companies may continue to sell OTC products containing oral phenylephrine for nasal decongestion.

Dosage 104

Dosage Labelling 104

pharmaphorum

NOVEMBER 7, 2024

Nasdaq-listed CDMO Avid Bioservices has agreed a $1.

110

110

Pharmaceutical Technology

NOVEMBER 7, 2024

The EMA has granted approval for Sanofi/Regeneron’s Dupixent (dupilumab) to treat EoE in children as young as one.

105

105

pharmaphorum

NOVEMBER 7, 2024

NICE has recommended broad use of Blueprint Medicines' recently-approved therapy for rare blood disorder advanced systemic mastocytosis

105

105

Advertisement

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

The Pharmacist

NOVEMBER 7, 2024

NICE has emphasised the importance of HRT in new guidance and clarified that cognitive behavioural therapy (CBT) should be an ‘add on’ treatment for menopausal symptoms. In its updated guidance, NICE has encouraged healthcare professionals to have ‘informed conversations’ with patients about the risks and benefits of HRT, and included a new ‘discussion aid’ to use […] The post New NICE guidance clarifies HRT as ‘first line treatment’ for menopause symptoms appeared first on The Pharmacist.

111

111

PharmaVoice

NOVEMBER 7, 2024

Dealmaking this year has been largely muted, but M&A trends are pointing to the areas where pharma is placing the most emphasis.

100

100

Pharmaceutical Technology

NOVEMBER 7, 2024

Lord Vallance stated the government sees investment, innovation, and public-private partnership as crucial to UK healthcare.

98

98

pharmaphorum

NOVEMBER 7, 2024

Discover the latest metrics and updates on the UK's VPAG (Voluntary scheme for branded medicines Pricing, Access and Growth) from NICE (National Institute for Health and Care Excellence). Stay informed on this work in progress.

97

97

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

Pharmaceutical Technology

NOVEMBER 7, 2024

The company reported that it does not have sufficient cash reserves to operate for the next 12 months, can only fund operations into Q1 2025.

98

98

Outsourcing Pharma

NOVEMBER 7, 2024

Wegovy manufacturer Ascendis Pharma has been tasked with supporting the development of a once-monthly GLP-1 drug.

89

89

World Pharma News

NOVEMBER 7, 2024

Scientists have uncovered how certain E. coli bacteria in the gut promote colon cancer by binding to intestinal cells and releasing a DNA-damaging toxin. The study, published in Nature, sheds light on a new approach to potentially reduce cancer risk. The study was performed by the teams of Prof. Lars Vereecke (VIB-UGent Center for Inflammation Research) and Prof.

88

88

Drug Patent Watch

NOVEMBER 7, 2024

The rising cost of prescription drugs has become a significant public health concern, with millions of Americans struggling to afford their medications. One crucial factor in mitigating this issue is the increased use of generic drugs. Generic drugs have been instrumental in reducing healthcare costs, and their impact cannot be overstated.

105

105

Advertisement

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

Outsourcing Pharma

NOVEMBER 7, 2024

The Taiwanese biotech has launched a phase 1/2 trial to test its small molecule cancer therapy in children and young adults with relapsed or treatment resistant tumors.

71

71

The Script

NOVEMBER 7, 2024

Do you consider yourself an introvert? Our team at Rx relief explains a few pharmaceutical positions you'd thrive in.

67

67

PharmaTech

NOVEMBER 7, 2024

A genetic medicines customer has selected the company’s binders for commercial development of the customer’s product.

64

64

Pharma Marketing Network

NOVEMBER 7, 2024

In today’s digital world, healthcare email marketing is more than just sending out newsletters. It’s a strategic tool that, when done right, can boost engagement, nurture relationships with healthcare professionals (HCPs), and increase brand awareness. But how can pharma companies truly maximize the potential of email marketing? Let’s dive in and explore some proven strategies.

HIPAA 52

HIPAA Communication Diabetes 52

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

BioPharma Dive

NOVEMBER 7, 2024

Sales of Moderna’s COVID-19 shot exceeded expectations, but the company’s launch of its new RSV vaccine has started slowly.

Vaccines 63

Vaccines 63

EMCrit Project

NOVEMBER 7, 2024

All the RACC Literature Goodness for November 2024 EMCrit Project by Scott Weingart, MD FCCM.

63

63

Pharmacy Times

NOVEMBER 7, 2024

In addition to GLP-1s, dual GLP-1 and GIP agonists, intestinal lipase inhibitors, sympathomimetics, and other agents can help patients lose weight.

59

59

Drug Channels

NOVEMBER 7, 2024

Today’s guest post comes from Chris Dowd, Senior VP of Market Development at ConnectiveRx. Chris examines three key trends that will affect patient support programs: the Inflation Reduction Act (IRA), legal/regulatory battles over copay adjustment programs, and uncertainties following a national election. He then outlines three actions that should guide manufacturers' preparation.

75

75

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

PharmaTech

NOVEMBER 7, 2024

The merger agreement is valued at approximately $1.1 billion.

59

59

Pharmacy Times

NOVEMBER 7, 2024

Efforts include a mandatory intravenous immunoglobulin ordering form, blood bank gatekeeping, and a stewardship committee to ensure optimized use.

57

57

Pharmaceutical Business Review

NOVEMBER 7, 2024

This partnership leverages SpectronRx’s advanced facilities for late-stage clinical and commercial supplies of the therapy. SpectronRx and Plus Therapeutics collaboration is set to accelerate nuclear medicine and improve supply chain redundancy for the production of Rhenium (186Re) Obisbemeda to meet upcoming commercial requirements and clinical trials.

52

52

Pharmacy Times

NOVEMBER 7, 2024

Children with certain atopic conditions, including asthma and common food allergies, were observed to have a higher risk of developing the chronic disorder.

55

55

PharmaTech

NOVEMBER 7, 2024

Parenteral drugs are becoming increasingly complex, creating new challenges and opportunities. This paper explores potential innovations across the entire value chain.

Packaging 52

Packaging 52